Published in Diabetes Metab J on June 01, 2013
What we talk about when we talk about fat. Cell (2014) 4.12
The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Rep (2016) 0.96
Obesity and cytokines in childhood-onset systemic lupus erythematosus. J Immunol Res (2014) 0.83
Systems genetics of obesity in an F2 pig model by genome-wide association, genetic network, and pathway analyses. Front Genet (2014) 0.82
Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes. Cardiovasc Diabetol (2015) 0.81
Asthma and metabolic syndrome: Current knowledge and future perspectives. World J Clin Cases (2015) 0.80
Anti-adipogenic effect of mulberry leaf ethanol extract in 3T3-L1 adipocytes. Nutr Res Pract (2014) 0.79
Deficiency in adipocyte chemokine receptor CXCR4 exacerbates obesity and compromises thermoregulatory responses of brown adipose tissue in a mouse model of diet-induced obesity. FASEB J (2014) 0.79
The association between metabolic health, obesity phenotype and the risk of breast cancer. Int J Cancer (2017) 0.79
CCL2 Serum Levels and Adiposity Are Associated with the Polymorphic Phenotypes -2518A on CCL2 and 64ILE on CCR2 in a Mexican Population with Insulin Resistance. J Diabetes Res (2015) 0.77
The Dietary Isoflavone Daidzein Reduces Expression of Pro-Inflammatory Genes through PPARα/γ and JNK Pathways in Adipocyte and Macrophage Co-Cultures. PLoS One (2016) 0.77
TM-25659-Induced Activation of FGF21 Level Decreases Insulin Resistance and Inflammation in Skeletal Muscle via GCN2 Pathways. Mol Cells (2015) 0.77
Simvastatin does not reduce chemokine production in obesity without comorbidities. Inflammation (2015) 0.76
Effects of exercise on brain functions in diabetic animal models. World J Diabetes (2015) 0.76
TREM-1 associated macrophage polarization plays a significant role in inducing insulin resistance in obese population. J Transl Med (2017) 0.75
Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice. Mol Ther Nucleic Acids (2016) 0.75
Obesity Mediates the Association between Mediterranean Diet Consumption and Insulin Resistance and Inflammation in US Adults. J Nutr (2017) 0.75
Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome. PLoS One (2016) 0.75
Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci (2016) 0.75
Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT 5-8 and -173 G>C): relationship with mRNA expression and soluble MIF levels in young obese subjects. Dis Markers (2015) 0.75
Analysis of the correlation between serum resistin and the variability of erythropoietin responsiveness in patients with chronic kidney disease. Exp Ther Med (2015) 0.75
Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study. BMC Complement Altern Med (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Cancer-related inflammation. Nature (2008) 34.21
Inflammation and metabolic disorders. Nature (2006) 33.33
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Chemokines and leukocyte traffic. Nature (1998) 9.79
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev (2000) 8.15
T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation (2007) 6.23
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes (2005) 5.68
Chemokines and disease. Nat Immunol (2001) 5.62
Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol (2008) 5.61
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem (2006) 5.57
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med (1989) 4.64
Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med (1989) 3.89
Inflamed fat: what starts the fire? J Clin Invest (2006) 3.11
Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol (2002) 2.92
Adipose tissue as a source of hormones. Am J Clin Nutr (1987) 2.57
Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes (2007) 2.54
CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab (2008) 2.14
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes (2010) 1.86
Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem (2007) 1.75
Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes (2008) 1.72
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab (2009) 1.68
CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes (2012) 1.56
Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. J Biol Chem (2009) 1.34
Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin Appl (2011) 1.11